SetPoint System
SetPoint Medical · Decision date Jul 30, 2025
What did the FDA approve?
FDA records P240039 as an original PMA application. The recorded decision is approval, dated Jul 30, 2025.
FDA approval order statement
The SetPoint System is indicated for use in the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response, loss of response, or intolerance to one or more biological or targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs).
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Jul 30, 2025
Regulatory record facts
- Identifier
- P240039
- Regulatory pathway
- Premarket approval application
- Applicant
- SetPoint Medical
- Product code
- SFJ
- Decision code
- APPR
- Decision date
- Jul 30, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vagus nerve stimulator for rheumatoid arthritis.
- Applicant
- SetPoint Medical
- Product code
- SFJ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P240039 received
Application receipt date recorded by FDA.
P240039 · FDA decision
APPR
P240039/S003 · Related supplement
Charger SetPoint System
P240039/S004 · Related supplement
SetPoint System
Timeline entries are records held by MedtechLedger for P240039. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240039
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Charger SetPoint SystemP240039/S003 | SetPoint Medical | PMA supplement | Oct 16, 2026 | FDA |
SetPoint SystemP240039/S004 | SetPoint Medical | PMA supplement | Oct 29, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
SetPoint Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 25101 Rye Canyon Loop, Valencia, CA, 91355
Sources and methodology
- Original FDA record: P240039
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
